ID: ALA3588908

Max Phase: Preclinical

Molecular Formula: C12H17NO3

Molecular Weight: 223.27

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1ccccc1OCC1CNCCO1

Standard InChI:  InChI=1S/C12H17NO3/c1-14-11-4-2-3-5-12(11)16-9-10-8-13-6-7-15-10/h2-5,10,13H,6-9H2,1H3

Standard InChI Key:  CHUROPRTMCQLIS-UHFFFAOYSA-N

Associated Targets(Human)

Alpha-2c adrenergic receptor 4876 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 223.27Molecular Weight (Monoisotopic): 223.1208AlogP: 1.06#Rotatable Bonds: 4
Polar Surface Area: 39.72Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 8.19CX LogP: 1.13CX LogD: 0.28
Aromatic Rings: 1Heavy Atoms: 16QED Weighted: 0.83Np Likeness Score: -0.14

References

1. Szőllősi E, Bobok A, Kiss L, Vass M, Kurkó D, Kolok S, Visegrády A, Keserű GM..  (2015)  Cell-based and virtual fragment screening for adrenergic α2C receptor agonists.,  23  (14): [PMID:25648685] [10.1016/j.bmc.2015.01.013]

Source